{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:01:59Z","timestamp":1790823719341,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jmii.2024.07.013","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:34:08Z","timestamp":1722645248000},"page":"833-839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Chronic pulmonary aspergillosis in Taiwan: Disease burden, diagnosis, treatment, and outcomes"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6334-2388","authenticated-orcid":false,"given":"Chih-Cheng","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2024.07.013_bib1","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jmii.2018.09.006","article-title":"Invasive mold infections in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"52","author":"Chien","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2024.07.013_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jmii.2020.09.004","article-title":"COVID-19 associated with pulmonary aspergillosis: a literature review","volume":"54","author":"Lai","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2024.07.013_bib3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cmi.2024.01.005","article-title":"Risk factors for invasive fungal infections after haematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"30","author":"Biyun","year":"2024","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 2","key":"10.1016\/j.jmii.2024.07.013_bib4","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2024.07.013_bib5","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jmii.2022.12.004","article-title":"COVID-19 associated mold infections: review of COVID-19 associated pulmonary aspergillosis and mucormycosis","volume":"56","author":"Huang","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2024.07.013_bib6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jmii.2021.09.001","article-title":"COVID-19 associated with concomitant mucormycosis and aspergillosis","volume":"55","author":"Lai","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2024.07.013_bib7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","author":"Kosmidis","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.jmii.2024.07.013_bib8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00061-2024","article-title":"Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis\/mycoses","volume":"63","author":"Agarwal","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jmii.2024.07.013_bib9","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3390\/jof7110922","article-title":"The impacts of Aspergillosis on outcome, burden and risks for mortality in influenza patients with critical illness","volume":"7","author":"Chao","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jmii.2024.07.013_bib10","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2024.07.013_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1055\/s-0043-1776914","article-title":"Chronic pulmonary aspergillosis: clinical presentation and management","volume":"45","author":"Evans","year":"2024","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2024.07.013_bib12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jmii.2024.07.013_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4269\/ajtmh.22-0366","article-title":"Imaging spectrum in chronic pulmonary Aspergillosis","volume":"108","author":"Garg","year":"2023","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jmii.2024.07.013_bib14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1183\/09031936.00054810","article-title":"Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma","volume":"37","author":"Smith","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jmii.2024.07.013_bib15","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3390\/jof7060480","article-title":"Establishing Aspergillus-specific IgG cut-off level for chronic pulmonary Aspergillosis diagnosis: multicenter prospective cohort study","volume":"7","author":"Lee","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jmii.2024.07.013_bib16","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/myc.13143","article-title":"Diagnostic cut-off value for Aspergillus fumigatus- and flavus-specific IgG with clinical relevance in chronic pulmonary Aspergillus infection: a pilot study in Taiwan","volume":"63","author":"Huang","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.jmii.2024.07.013_bib17","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3390\/jof7100842","article-title":"Chronic pulmonary Aspergillosis: disease severity using image analysis and correlation with systemic proinflammation and predictors of clinical outcome","volume":"7","author":"Huang","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jmii.2024.07.013_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1060727","article-title":"Comparison of Aspergillus-specific antibody cut-offs for the diagnosis of aspergillosis","volume":"13","author":"Hsiao","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jmii.2024.07.013_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/14787210.2018.1558054","article-title":"Improving the rates of Aspergillus detection: an update on current diagnostic strategies","volume":"17","author":"Jenks","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jmii.2024.07.013_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jinf.2015.11.003","article-title":"Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA)","volume":"72","author":"Page","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.jmii.2024.07.013_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.diagmicrobio.2018.01.001","article-title":"Receiver operating characteristic curve analysis of four Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis","volume":"91","author":"Page","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2024.07.013_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/mmy\/myw116","article-title":"Aspergillus serology: have we arrived yet?","volume":"55","author":"Richardson","year":"2017","journal-title":"Med Mycol"},{"key":"10.1016\/j.jmii.2024.07.013_bib23","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.3389\/fmicb.2018.01810","article-title":"Recent advances in diagnosing chronic pulmonary Aspergillosis","volume":"9","author":"Takazono","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jmii.2024.07.013_bib24","doi-asserted-by":"crossref","first-page":"1091.e1","DOI":"10.1016\/j.cmi.2019.12.009","article-title":"Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study","volume":"26","author":"Lee","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jmii.2024.07.013_bib25","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02950-2021","article-title":"Treatment outcome definitions in chronic pulmonary aspergillosis: a CPAnet consensus statement","volume":"59","author":"Van Braeckel","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jmii.2024.07.013_bib26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/myc.13324","article-title":"Anti-fungal agents in the treatment of chronic pulmonary aspergillosis: systematic review and a network meta-analysis","volume":"64","author":"Sehgal","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.jmii.2024.07.013_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240374","article-title":"Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: a systematic review and meta-analysis","volume":"15","author":"Olum","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2024.07.013_bib28","article-title":"Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges","volume":"11","author":"Tashiro","year":"2024","journal-title":"Ther Adv Infect Dis"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118224001245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118224001245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T16:33:46Z","timestamp":1737390826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118224001245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1684118224001245"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2024.07.013","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic pulmonary aspergillosis in Taiwan: Disease burden, diagnosis, treatment, and outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2024.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC\u00e9","name":"copyright","label":"Copyright"}]}}